Evaluating the contribution of rare variants to type 2 diabetes and related traits using pedigrees.

Proc Natl Acad Sci U S A
Authors
Keywords
Abstract

A major challenge in evaluating the contribution of rare variants to complex disease is identifying enough copies of the rare alleles to permit informative statistical analysis. To investigate the contribution of rare variants to the risk of type 2 diabetes (T2D) and related traits, we performed deep whole-genome analysis of 1,034 members of 20 large Mexican-American families with high prevalence of T2D. If rare variants of large effect accounted for much of the diabetes risk in these families, our experiment was powered to detect association. Using gene expression data on 21,677 transcripts for 643 pedigree members, we identified evidence for large-effect rare-variant -expression quantitative trait loci that could not be detected in population studies, validating our approach. However, we did not identify any rare variants of large effect associated with T2D, or the related traits of fasting glucose and insulin, suggesting that large-effect rare variants account for only a modest fraction of the genetic risk of these traits in this sample of families. Reliable identification of large-effect rare variants will require larger samples of extended pedigrees or different study designs that further enrich for such variants.

Year of Publication
2018
Journal
Proc Natl Acad Sci U S A
Volume
115
Issue
2
Pages
379-384
Date Published
2018 01 09
ISSN
1091-6490
DOI
10.1073/pnas.1705859115
PubMed ID
29279374
PubMed Central ID
PMC5777025
Links
Grant list
U01 DK085501 / DK / NIDDK NIH HHS / United States
R01 DK078616 / DK / NIDDK NIH HHS / United States
R01 HL113323 / HL / NHLBI NIH HHS / United States
090532 / Wellcome Trust / United Kingdom
U01 DK085524 / DK / NIDDK NIH HHS / United States
U01 DK085545 / DK / NIDDK NIH HHS / United States
R01 DK098032 / DK / NIDDK NIH HHS / United States
Department of Health / United Kingdom
R01 DK047482 / DK / NIDDK NIH HHS / United States
U01 DK105535 / DK / NIDDK NIH HHS / United States
P30 DK098722 / DK / NIDDK NIH HHS / United States
U01 DK085526 / DK / NIDDK NIH HHS / United States
P30 DK020541 / DK / NIDDK NIH HHS / United States
090367 / Wellcome Trust / United Kingdom
U01 DK085584 / DK / NIDDK NIH HHS / United States
U01 DK078616 / DK / NIDDK NIH HHS / United States
P30 DK020572 / DK / NIDDK NIH HHS / United States
Wellcome Trust / United Kingdom
098381 / Wellcome Trust / United Kingdom
U54 GM115428 / GM / NIGMS NIH HHS / United States
G0601261 / Medical Research Council / United Kingdom
P30 DK020595 / DK / NIDDK NIH HHS / United States
R01 DK053889 / DK / NIDDK NIH HHS / United States